The magnitude of weight loss also raises questions about how early these therapies might be used in disease progression
| Second Natures medication programmes No, Wegovy isnt a drug that most people will need to be on for life
Most clinicians recommend starting GLP-1 first, stabilizing through the dose escalation phase, and then adding carbohydrate restriction once medication effects are predictable
Third, any program's answer to "what happens to my plan if compounding is further restricted" tells you how prepared it is
3 Results 3.1 Characteristics of the included studies The search included 331 potentially relevant articles after examining the titles/summary, excluding 290 studies because they were duplicate publications or because they did not evaluate the purpose of this study
Acta Diabetol 60(9):12571266 Berra C, Manfrini R, Bifari F, Cipponeri E, Ghelardi R, Centofanti L et al (2024) Improved glycemic and weight control with dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting